Weiss Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-332,175
Closed -$3.3M 649
2022
Q3
$3.3M Hold
332,175
0.08% 317
2022
Q2
$3.27M Sell
332,175
-1,130,324
-77% -$11.1M 0.08% 303
2022
Q1
$14.3M Buy
1,462,499
+330,299
+29% +$3.26M 0.3% 76
2021
Q4
$11.2M Buy
1,132,200
+937,849
+483% +$9.32M 0.24% 109
2021
Q3
$1.93M Buy
+194,351
New +$1.9M 0.05% 330

Other funds holding TLSI

Weiss Asset Management's TLSI Position: Q4 2022 in Review

Weiss Asset Management sold out of TriSalus Life Sciences (TLSI) in Q4 2022, closing a stake of 332,175 shares — an estimated $3.3M sold.

Weiss Asset Management first reported a position in TLSI in Q3 2021 and held it in 5 quarters. The position peaked at $14.3M in Q1 2022. 9 funds tracked by Wall St. Rank hold TLSI as of Q4 2022.

  • Weiss Asset Management reported no remaining TriSalus Life Sciences position as of Q4 2022 after selling out during the quarter.
  • Weiss Asset Management sold 332,175 TriSalus Life Sciences shares in Q4 2022, an estimated $3.3M.
  • Weiss Asset Management first reported a position in TriSalus Life Sciences in Q3 2021 and held it in 5 quarters.
  • Weiss Asset Management's TriSalus Life Sciences position peaked at $14.3M in Q1 2022.
  • 9 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q4 2022.

Based on Weiss Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.